Want to join the conversation?
For FY17, $BRC expects organic sales to range from a low single-digit decline to slightly positive growth and diluted earnings of Class A common share to range between $1.55-1.70. This earnings guidance range is based on foreign currency exchange rates as of July 31, 2016, which are expected to reduce FY17 revenues by approx. 1.5%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?